Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies

Arthritis Research and Therapy

Volumn 6, Issue 4, 2004, Pages

  Conti, Fabrizio ^a   Alessandri, Cristiano ^a   Bompane, Daniela ^a   Bombardieri, Michele ^a   Spinelli, Francesca Romana ^a   Rusconi, Anna Carlotta ^a   Valesini, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

anti endothelial cell antibodies; autoantibodies; mood disorders; psychiatric disorders; systemic lupus erythematosus

Indexed keywords

ANTI-ENDOTHELIAL CELL ANTIBODY; AUTOANTIBODY; ENDOTHELIAL CELL ANTIBODY;

ADULT; ARTICLE; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PHYSIOLOGY; PSYCHOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AUTOANTIBODIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS;

EID: 16644386029     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1198     Document Type: Article

References (58)

1. ACR ad hoc committee on Neuropsychiatric Lupus Nomenclature: The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999, 42: 599-608. 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F. DOI: 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F
2. Ainiala H, Hietaharju A, Loukkola J, Peltola J, Korpela M, Metsanoja R, Auvinen A: Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum. 2001, 45: 419-423. 10.1002/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-X. DOI: 10.1002/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-X
3. Buchbinder R, Hall S, Littlejohn GO, Ryan PF: Neuropsychiatric manifestations of systemic lupus erythematosus. Aust N Z J Med. 1988, 18: 679-684. DOI: 10.1111/j.1445-5994.1988.tb00150.x
4. Johnson RT, Richardson EP: The neurological manifestations of systemic lupus erythematosus. Medicine. 1968, 47: 337-369. DOI: 10.1097/00005792-196807000-00002
5. Wekking EM: Psychiatric symptoms in systemic lupus erythematosus: an update. Psychosom Med. 1993, 55: 219-228. DOI: 10.1097/00006842-199303000-00011
6. Iverson GL, McCracken LM: Attributing psychopathology to systemic lupus erythematosus: some methodological considerations. Ann Rheum Dis. 1992, 51: 134-135. DOI: 10.1136/ard.51.1.134
7. Lewis DA, Smith RE: Steroid induced psychiatric syndromes: a report of 14 cases and review of literature. J Affect Disord. 1983, 5: 319-332. 10.1016/0165-0327(83)90022-8. DOI: 10.1016/0165-0327(83)90022-8
8. Hay EM, Black D, Huddy A, Creed F, Tomenson B, Bernstein RM, Holt PJ: Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum. 1992, 35: 411-416. DOI: 10.1002/art.1780350409
9. Lindal E, Thorlacius S, Steinsson K, Stefansson JG: Psychiatric disorders among subjects with systemic lupus erythematosus in an unselected population. Scand J Rheumatol. 1995, 24: 346-351. DOI: 10.3109/03009749509095179
10. Segui J, Ramos-Casals M, Garcia-Carrasco M, de Flores T, Cervera R, Valdes M, Font J, Ingelmo M: Psychiatric and psychosocial disorders in patients with systemic lupus erythematosus: a longitudinal study of active and inactive stages of the disease. Lupus. 2000, 9: 584-588. 10.1191/096120300678828730. DOI: 10.1191/096120300678828730
11. Shortall E, Isenberg D, Newman SP: Factors associated with mood and mood disorders in SLE. Lupus. 1995, 4: 272-279. DOI: 10.1177/096120339500400407
12. Greenwood DL, Gitlits VM, Alderuccio F, Sentry JW, Toh BH: Autoantibodies in neuropsychiatric lupus. Autoimmunity. 2002, 35: 79-86. 10.1080/08916930290016547. DOI: 10.1080/08916930290016547
13. Bonfa E, Elkon KB: Clinical and serologic associations of the antiribosomal P protein antibody. Arthritis Rheum. 1986, 29: 981-985. DOI: 10.1002/art.1780290806
14. Teh LS, Isenberg DA: Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal. Arthritis Rheum. 1994, 37: 307-315. DOI: 10.1002/art.1780370303
15. Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N, Elkon KB: Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med. 1987, 317: 265-271. DOI: 10.1056/NEJM198707303170503
16. Isshi K, Hirohata S: Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 1996, 39: 1483-1490. DOI: 10.1002/art.1780390907
17. Schneebaum AB, Singleton JD, West SG, Blodgett JK, Allen LG, Cheronis JC, Kotzin BL: Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med. 1991, 90: 54-62. 10.1016/0002-9343(91)90506-S. DOI: 10.1016/0002-9343(91)90506-S
18. Teh LS, Bedwell AE, Isenberg DA, Gordon C, Emery P, Charles PJ, Harper M, Amos N, Williams BD: Antibodies to protein P in systemic lupus erythematosus. Ann Rheum Dis. 1992, 51: 489-494. DOI: 10.1136/ard.51.4.489
19. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40: 1725- DOI: 10.1002/art.1780400928
20. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 1994, Washington, DC: American Psychiatric Association, 4
21. First MB, Spitzer RL, Gibbon M, Williams JB: Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I/P), Computer Program Handbook. Version 2.0. 1996, New York: New York State Psychiatric Institute, Biometrics Research Department
22. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992, 35: 630-640. DOI: 10.1002/art.1780350606
23. Vismara A, Meroni PL, Tincani A, Harris EN, Barcellini W, Brucato A, Khamashta M, Hughes GR, Zanussi C, Balestrieri G: Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol. 1988, 74: 247-253.
24. van der Zee JM, Siegert CE, de Vreede TA, Daha MR, Breedveld FC: Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE). Clin Exp Immunol. 1991, 84: 238-244.
25. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980, 23: 581-590. DOI: 10.1002/art.1780230510
26. Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, Valdez CR, Escalante A, del Rincon I, Gronseth G, Rhine CB, Padilla P, McGlasson D: Neuropsychiatric syndromes in lupus: prevalence using standardized definition. Neurology. 2002, 58: 1214-1220. DOI: 10.1212/WNL.58.8.1214
27. Mok CC, Lau CS, Wong RWS: Neuropsychiatric manifestations and their clinical associations in Southern Chinese patients with systemic lupus erythematosus. J Rheumatol. 2001, 28: 766-771.
28. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A: The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology. 2001, 57: 496-500. DOI: 10.1212/WNL.57.3.496
29. D'Cruz DP, Houssiau FA, Ramirez G, Baguley E, McCutcheon J, Vianna J, Haga HJ, Swana GT, Khamashta MA, Taylor JC: Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis. Clin Exp Immunol. 1991, 85: 254-261. DOI: 10.1111/j.1365-2249.1991.tb05714.x
30. Carvalho D, Savage CO, Black CM, Pearson JD: IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J Clin Invest. 1996, 97: 111-119. DOI: 10.1172/JCI118377
31. Bordron A, Dueymes M, Levy Y, Jamin C, Leroy JP, Piette JC, Shoenfeld Y, Youinou PY: The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest. 1998, 101: 2029-2035. DOI: 10.1172/JCI2261
32. Del Papa N, Guidali L, Spatola L, Bonara P, Borghi MO, Tincani A, Balestrieri G, Meroni PL: Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol. 1995, 13: 179-185.
33. Del Papa N, Guidali L, Sala A, Buccellati C, Khamashta MA, Ichikawa K, Koike T, Balestrieri G, Tincani A, Hughes GR, Meroni PL: Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum. 1997, 40: 551-561. DOI: 10.1002/art.1780400322
34. Papa ND, Raschi E, Moroni G, Panzeri P, Borghi MO, Ponticelli C, Tincani A, Balestrieri G, Meroni PL: Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro. Lupus. 1999, 8: 423-429. DOI: 10.1177/096120339900800603
35. Wellicome SM, Kapahi P, Mason JC, Lebranchu Y, Yarwood H, Haskard DO: Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol. 1993, 92: 412-418. DOI: 10.1111/j.1365-2249.1993.tb03413.x
36. Belmont HM, Buyon J, Giorno R, Abramson S: Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited. Arthritis Rheum. 1994, 37: 376-383. DOI: 10.1002/art.1780370311
37. Carson CW, Beall LD, Hunder GG, Johnson CM, Newman W: Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus. J Rheumatol. 1993, 20: 809-814.
38. Song J, Park YB, Lee WK, Lee KH, Lee SK: Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Rheumatol Int. 2000, 20: 1-7. 10.1007/s002960000060. DOI: 10.1007/s002960000060
39. Meroni PL, Tincani A, Sepp N, Raschi E, Testoni C, Corsini E, Cavazzana I, Pellegrini S, Salmaggi A: Endothelium and the brain in CNS lupus. Lupus. 2003, 12: 919-928. 10.1191/0961203303lu503oa. DOI: 10.1191/0961203303lu503oa
40. Harris EN, Gharavi AE, Asherson RA, Boey ML, Hughes GR: Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol. 1984, 2: 47-51.
41. Asherson RA, Khamashta MA, Gil A, Vazquez JJ, Chan O, Baguley E, Hughes GR: Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med. 1989, 86: 391-399. 10.1016/0002-9343(89)90335-5. DOI: 10.1016/0002-9343(89)90335-5
42. Herranz MT, Rivier G, Khamashta MA, Blaser KU, Hughes GR: Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum. 1994, 37: 568-571. DOI: 10.1002/art.1780370418
43. Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A, Hughes GR: Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol. 2003, 30: 985-992.
44. Caronti B, Calderaro C, Alessandri C, Conti F, Tinghino R, Pini C, Palladini G, Valesini G: Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells. J Autoimmun. 1998, 11: 425-429. 10.1006/jaut.1998.0214. DOI: 10.1006/jaut.1998.0214
45. Caronti B, Calderaro C, Alessandri C, Conti F, Tinghino R, Palladini G, Valesini G: Beta2-glycoprotein I (beta2-GPI) mRNA is expressed by several cell types involved in anti-phospholipid syndrome-related tissue damage. Clin Exp Immunol. 1999, 115: 214-219. 10.1046/j.1365-2249.1999.00770.x. DOI: 10.1046/j.1365-2249.1999.00770.x
46. Chan TM, Yu PM, Tsang KL, Cheng IK: Endothelial cell binding by human polyclonal anti-DNA antibodies: relationship to disease activity and endothelial functional alterations. Clin Exp Immunol. 1995, 100: 506-513. DOI: 10.1111/j.1365-2249.1995.tb03730.x
47. Chan TM, Cheng IK: Identification of endothelial cell membrane proteins that bind anti-DNA antibodies from patients with systemic lupus erythematosus by direct or indirect mechanisms. J Autoimmun. 1997, 10: 433-439. 10.1006/jaut.1997.9998. DOI: 10.1006/jaut.1997.9998
48. Moscato S, Pratesi F, Bongiorni F, Scavuzzo MC, Chimenti D, Bombardieri S, Migliorini P: Endothelial cell binding by systemic lupus antibodies: functional properties and relationship with anti-DNA activity. J Autoimmun. 2002, 18: 231-238. 10.1006/jaut.2002.0583. DOI: 10.1006/jaut.2002.0583
49. Arnett FC, Reveille JD, Moutsopoulos HM, Georgescu L, Elkon KB: Ribosomal P autoantibodies in SLE. Arthritis Rheum. 1996, 39: 1833-1839. DOI: 10.1002/art.1780391109
50. Gerli R, Caponi L, Tincani A, Scorza R, Sabbadini MG, Danieli MG, De Angelis V, Cesarotti M, Piccirilli M, Quartesan R, Moretti P, Cantoni C, Franceschini F, Cavazzana I, Origgi L, Vanoli M, Bozzolo E, Ferrario L, Padovani A, Gambini O, Vanzulli L, Croce D, Bombardieri S: Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. Rheumatology. 2002, 41: 1357-1366. 10.1093/rheumatology/41.12.1357. DOI: 10.1093/rheumatology/41.12.1357
51. Yoshio T, Masuyama J, Ikeda M, Tamai K, Hachiya T, Emori T, Mimori A, Takeda A, Minota S, Kano S: Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus. J Rheumatol. 1995, 22: 1681-1687.
52. Frampton G, Moriya S, Pearson JD, Isenberg DA, Ward FJ, Smith TA, Panayiotou A, Staines NA, Murphy JJ: Identification of candidate endothelial cell autoantigens in systemic lupus erythematosus using a molecular cloning strategy: a role for ribosomal P protein P0 as an endothelial cell autoantigen. Rheumatology. 2000, 39: 1114-1120. 10.1093/rheumatology/39.10.1114. DOI: 10.1093/rheumatology/39.10.1114
53. Sanna G, Piga M, Terryberry JW, Peltz MT, Giagheddu S, Satta L, Ahmed A, Cauli A, Montaldo C, Passiu G, Peter JB, Shoenfeld Y, Mathieu A: Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus. 2000, 9: 573-583. 10.1191/096120300678828695. DOI: 10.1191/096120300678828695
54. Kato S, Gondo T, Hoshii Y, Takahashi M, Yamada M, Ishihara T: Confocal observation of senile plaques in Alzheimer's disease: senile plaque morphology and relationship between senile plaques and astrocytes. Pathol Int. 1998, 48: 332-340. DOI: 10.1111/j.1440-1827.1998.tb03915.x
55. Tanaka J, Nakamura K, Takeda M, Tada K, Suzuki H, Morita H, Okado T, Hariguchi S, Nishimura T: Enzyme-linked immunosorbent assay for human autoantibody to glial fibrillary acidic protein: higher titer of the antibody is detected in serum of patients with Alzheimer's disease. Acta Neurol Scand. 1989, 80: 554-560. DOI: 10.1111/j.1600-0404.1989.tb03926.x
56. Newcombe J, Gahan S, Cuzner ML: Serum antibodies against central nervous system proteins in human demyelinating disease. Clin Exp Immunol. 1985, 59: 383-390.
57. Trysberg E, Nylen K, Rosengren LE, Tarkowski A: Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum. 2003, 48: 2881-2887. 10.1002/art.11279. DOI: 10.1002/art.11279
58. Utset TO, Golden M, Siberry G, Kiri N, Crum RM, Petri M: Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjogren's syndrome. J Rheumatol. 1994, 21: 2039-2045.